These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 23668332

  • 1. Safety evaluation of leflunomide in rheumatoid arthritis.
    Keen HI, Conaghan PG, Tett SE.
    Expert Opin Drug Saf; 2013 Jul; 12(4):581-8. PubMed ID: 23668332
    [Abstract] [Full Text] [Related]

  • 2. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [Abstract] [Full Text] [Related]

  • 3. Leflunomide Aventis Pharma.
    Kaplan MJ.
    Curr Opin Investig Drugs; 2001 Feb; 2(2):222-30. PubMed ID: 11816835
    [Abstract] [Full Text] [Related]

  • 4. Leflunomide in clinical practice.
    Pinto P, Dougados M.
    Acta Reumatol Port; 2006 Feb; 31(3):215-24. PubMed ID: 17094333
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.
    Smolen JS, Emery P, Kalden JR, Van Riel PL, Dougados M, Strand CV, Breedveld FC.
    J Rheumatol Suppl; 2004 Jun; 71():13-20. PubMed ID: 15170903
    [Abstract] [Full Text] [Related]

  • 6. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
    Goldenberg MM.
    Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
    [Abstract] [Full Text] [Related]

  • 7. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy of leflunomide].
    Hirohata S.
    Nihon Rinsho; 2002 Dec; 60(12):2357-63. PubMed ID: 12510362
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O, Gibofsky A.
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [Abstract] [Full Text] [Related]

  • 10. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C, Chen S, Gu Y, Lao Z, Ni L, Yu Q, Xu J, Li X, Liu J, Sun L, He P, Ma J, Xu S, Ding C.
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [Abstract] [Full Text] [Related]

  • 11. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F, Koehm M, Burkhardt H.
    Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
    [Abstract] [Full Text] [Related]

  • 12. [Leflunomide--a new disease modifying anti-rheumatic agent].
    Rødevand E, Kvien TK, Johnsen V.
    Tidsskr Nor Laegeforen; 2001 Nov 10; 121(27):3181-4. PubMed ID: 11876141
    [Abstract] [Full Text] [Related]

  • 13. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis.
    Murdaca G, Spanò F, Puppo F.
    Expert Opin Drug Saf; 2013 Nov 10; 12(6):801-4. PubMed ID: 23889669
    [Abstract] [Full Text] [Related]

  • 14. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients.
    Gupta R, Bhatia J, Gupta SK.
    Arzneimittelforschung; 2011 Nov 10; 61(5):312-6. PubMed ID: 21755815
    [Abstract] [Full Text] [Related]

  • 15. Leflunomide in the treatment of rheumatoid arthritis.
    Li EK, Tam LS, Tomlinson B.
    Clin Ther; 2004 Apr 10; 26(4):447-59. PubMed ID: 15189743
    [Abstract] [Full Text] [Related]

  • 16. [Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review].
    Molina Molina MI, Pinochet Paiva CM, Quezada Morales JI.
    Medwave; 2015 Dec 30; 15(11):e6350. PubMed ID: 26819061
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' Group.
    Rozman B.
    J Rheumatol Suppl; 1998 Jul 30; 53():27-32. PubMed ID: 9666415
    [Abstract] [Full Text] [Related]

  • 18. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M, Creemers MC, Welsing PM, van Riel PL.
    Rheumatology (Oxford); 2005 Apr 30; 44(4):472-8. PubMed ID: 15598707
    [Abstract] [Full Text] [Related]

  • 19. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.
    Rodriguez-Rodriguez L, Jover-Jover JA, Fontsere O, Peña-Blanco RC, León L, Fernández-Gutierrez B, Abásolo L.
    Scand J Rheumatol; 2013 Apr 30; 42(6):433-6. PubMed ID: 23742043
    [Abstract] [Full Text] [Related]

  • 20. Leflunomide for the treatment of rheumatoid arthritis.
    Olsen NJ, Strand V, Kremer JM.
    Bull Rheum Dis; 1999 Apr 30; 48(8):1-4. PubMed ID: 10628065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.